XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
Series A redeemable convertible preferred shares
Redeemable Convertible Preferred Shares
Series A+ redeemable convertible preferred shares
Redeemable Convertible Preferred Shares
Series B redeemable convertible preferred stock
Redeemable Convertible Preferred Shares
Series B1 redeemable convertible preferred stock
Redeemable Convertible Preferred Shares
Common shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2022 $ 32,001,000 $ 26,000,000 $ 133,015,000 $ 8,959,000          
Beginning balance (in shares) at Dec. 31, 2022 19,200,000 12,800,000 32,857,000 2,161,000          
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering $ (32,001,000) $ (26,000,000) $ (133,015,000) $ (8,959,000)          
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering (in Shares) (19,200,000) (12,800,000) (32,857,000) (2,161,000)          
Beginning balance at Dec. 31, 2022         $ 1,000 $ 1,921,000 $ (110,000) $ (116,952,000) $ (115,140,000)
Beginning balance (in shares) at Dec. 31, 2022         10,527,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering         $ 7,000 199,968,000     199,975,000
Conversion of redeemable convertible preferred shares into ordinary shares upon initial public offering (in shares)         67,018,000        
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount of $18,586         $ 3,000 166,667,000     166,670,000
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount of $18,586 (in shares)         37,053,000        
Net exercise of ordinary share warrants (in Shares)         106,000        
Issuance of ordinary shares upon exercise of vested share options           31,000     31,000
Issuance of ordinary shares upon exercise of vested share options (in shares)         26,000        
Share-based compensation expense           2,533,000     2,533,000
Unrealized (loss) gain on investments, net             257,000   257,000
Net loss               (17,975,000) (17,975,000)
Ending balance at Mar. 31, 2023         $ 11,000 371,120,000 147,000 (134,927,000) 236,351,000
Ending balance (in shares) at Mar. 31, 2023         114,730,000        
Beginning balance at Dec. 31, 2023                 0
Ending balance at Mar. 31, 2024                 0
Beginning balance at Dec. 31, 2023         $ 14,000 659,003,000 521,000 (206,572,000) $ 452,966,000
Beginning balance (in shares) at Dec. 31, 2023         139,220,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of ordinary shares upon initial public offering, net of issuance costs and underwriting discount of $18,586 (in shares)                 90,187,562
Issuance of ordinary shares upon exercise of vested share options           755,000     $ 755,000
Issuance of ordinary shares upon exercise of vested share options (in shares)         635,000       635,000
Share-based compensation expense           2,744,000     $ 2,744,000
Unrealized (loss) gain on investments, net             (611,000)   (611,000)
Net loss               (26,036,000) (26,036,000)
Ending balance at Mar. 31, 2024         $ 14,000 $ 662,502,000 $ (90,000) $ (232,608,000) $ 429,818,000
Ending balance (in shares) at Mar. 31, 2024         139,855,000